Literature DB >> 28905351

The Tissue Factor Pathway and Wound Healing.

Maureane Hoffman1.   

Abstract

The role of tissue factor (TF) as the major initiator of hemostatic blood coagulation is well recognized. The ability to form an adequate hemostatic clot is essential to the normal healing of an injury by staunching bleeding, stabilizing the injured tissue, and serving as a scaffold for repair processes. Also, some molecules produced during hemostasis, particularly thrombin, have cytokine and growth factor-like activities that contribute to inflammation and repair. However, TF itself has activities as a regulator of cellular processes via direct signaling, as well as by facilitating activation of proteolytically activated receptors by activated factors VII and X. The importance of hemostasis in the host response to injury makes it very difficult to separate the hemostatic from nonhemostatic effects of TF on wound healing. The literature in this area remains sparse but suggests that TF influences the course and tempo of healing by cell signaling events that impact inflammation, epithelialization, and angiogenesis. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28905351     DOI: 10.1055/s-0037-1606181

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  10 in total

1.  Antithrombotic Therapy: Prevention and Treatment of Atherosclerosis and Atherothrombosis.

Authors:  R H Olie; P E J van der Meijden; H M H Spronk; H Ten Cate
Journal:  Handb Exp Pharmacol       Date:  2022

Review 2.  Hemostasis components in cerebral amyloid angiopathy and Alzheimer's disease.

Authors:  Nicole Ziliotto; Francesco Bernardi; Fabrizio Piazza
Journal:  Neurol Sci       Date:  2021-05-27       Impact factor: 3.307

Review 3.  Cell-Cell Communication Breakdown and Endothelial Dysfunction.

Authors:  Daniel D Lee; Margaret A Schwarz
Journal:  Crit Care Clin       Date:  2020-01-31       Impact factor: 3.598

4.  Single-cell RNA-seq highlights heterogeneity in human primary Wharton's jelly mesenchymal stem/stromal cells cultured in vitro.

Authors:  Changbin Sun; Lei Wang; Hailun Wang; Tingrun Huang; Wenwen Yao; Jing Li; Xi Zhang
Journal:  Stem Cell Res Ther       Date:  2020-04-06       Impact factor: 6.832

5.  Tissue factor as a new target for CAR-NK cell immunotherapy of triple-negative breast cancer.

Authors:  Zhiwei Hu
Journal:  Sci Rep       Date:  2020-02-18       Impact factor: 4.379

Review 6.  The application of mesenchymal stromal cells (MSCs) and their derivative exosome in skin wound healing: a comprehensive review.

Authors:  Donghui Bian; Yan Wu; Guodong Song; Ramyar Azizi; Amir Zamani
Journal:  Stem Cell Res Ther       Date:  2022-01-24       Impact factor: 6.832

Review 7.  MSCs and their exosomes: a rapidly evolving approach in the context of cutaneous wounds therapy.

Authors:  Faroogh Marofi; Kozlitina Iuliia Alexandrovna; Ria Margiana; Mahta Bahramali; Wanich Suksatan; Walid Kamal Abdelbasset; Supat Chupradit; Maryam Nasimi; Marwah Suliman Maashi
Journal:  Stem Cell Res Ther       Date:  2021-12-04       Impact factor: 6.832

8.  Extracellular vesicles from hair follicle-derived mesenchymal stromal cells: isolation, characterization and therapeutic potential for chronic wound healing.

Authors:  Juan M Falcon-Perez; Rosa Maria Hernandez; Kevin Las Heras; Félix Royo; Clara Garcia-Vallicrosa; Manoli Igartua; Edorta Santos-Vizcaino
Journal:  Stem Cell Res Ther       Date:  2022-04-08       Impact factor: 6.832

Review 9.  Tumor-stromal crosstalk in pancreatic cancer and tissue fibrosis.

Authors:  Divya Thomas; Prakash Radhakrishnan
Journal:  Mol Cancer       Date:  2019-01-21       Impact factor: 27.401

Review 10.  Saponins as Modulators of the Blood Coagulation System and Perspectives Regarding Their Use in the Prevention of Venous Thromboembolic Incidents.

Authors:  Beata Olas; Karina Urbańska; Magdalena Bryś
Journal:  Molecules       Date:  2020-11-06       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.